- 现金
- 62111 元
- 精华
- 26
- 帖子
- 30437
- 注册时间
- 2009-10-5
- 最后登录
- 2022-12-28
|
Abstract 436
在确定真正的非活动性HBsAg携带者感染C基因型乙肝病毒,乙肝表面抗原中的作用
ROLE OF HEPATITIS B SURFACE ANTIGEN IN IDENTIFYING TRUE INACTIVE HBSAG CARRIERS INFECTED WITH GENOTYPE C HEPATITIS B VIRUS
S.Y. Yim*, S.H. Um, Y.S. Seo, H.S. Ryu
Internal Medicine, Korea University, Seoul, Republic of Korea. *[email protected]
Background and aim: Inactive and active phases of hepatitis B e antigen (HBeAg)-negative chronic hepatitis B virus (HBV) infection are diagnosed by serum HBV DNA levels, with cutoff at 2000 IU/mL. However, it is difficult to distinguish inactive carriers from HBeAg-negative chronic hepatitis B patients at a single time point because of frequently fluctuating HBV DNA levels in the latter group. Therefore we aimed to establish the role of serum hepatitis B surface antigen (HBsAg) in identifying “true inactive carriers” among treatment-naïve genotype C HBV-infected patients.
Methods: A total of 133 HBeAg-negative carriers with serum HBV DNA levels of < 2000 IU/mL and normal alanine aminotransferase levels were enrolled and followed up for >12 months. Baseline clinical characteristics, quantitative HBsAg using ARCHITECT assay, serum HBV DNA levels and biochemical factors were reviewed.
Results: Thirty-six patients (27%) showed HBV reactivation (HBV DNA, ≥2000 IU/mL) during 12 months from enrollment. Baseline serum HBsAg levels and HBV DNA levels were associated with HBV reactivation (both,P< 0.001). The predictive efficacy in identifying persistently inactive carriers was the highest for the combination of HBV DNA and HBsAg, followed by HBV DNA and HBsAg (AUROC=0.784, 0.735 and 0.722, all P< 0.001). However, no baseline serum HBV DNA levels could identify inactive carriers with 100% specificity, while baseline serum HBsAg levels (49.45 IU/mL) and combination of both (125 IU/mL and 332 IU/mL) identified true inactive carriers with 100% specificity and detection rate of 27.8%, 30.9%, respectively. Detection rate increased when different HBsAg cutoff levels were applied to different age groups according to median age (46 years). It was comparable in both younger and older groups (37.2% vs 35.2%) even when HBsAg cutoff level was increased in the former (488 IU/mL vs 49.45 IU/mL). Furthermore, no HBV reactivation occurred during long-term follow-up when these cutoff levels were applied.
Conclusion: Baseline serum HBsAg levels at a single time point can identify persistently true inactive carriers, with different cutoff levels according to age. Thus, frequent monitoring may be unnecessary for low-viremic patients with baseline serum HBsAg levels below these cutoff levels, considering the cost and low incidence of disease progression.
Assigned speakers:
Dr. Sun Young Yim, Korea University , Seoul , Republic of Korea
Assigned in sessions:
25.04.2013, 09:00-18:00, Poster Session, P01-07b, Category 07b: Viral Hepatitis B & D: Clinical (except therapy), Poster Area
|
|